Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Posted by  | Issues & Perspectives

Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30 years of basic research at Johns Hopkins and its Bloomberg~Kimmel Institute, pembroluzimab now can be used for colon, pancreatic, stomach, ovarian and other cancers if genetic testing reveals defects in(...)

Lung cancer immunotherapy options expand

Lung cancer immunotherapy options expand

Posted by  | Issues & Perspectives

Patients and doctors received news this week of the FDA’s approval of the immunotherapy drug pembrolizumab in combination with platinum doublet chemotherapy as first-line therapy for all patients with non-small cell lung cancer, irrespective of patients’ tumor PD-L1 status. The new approval follows the FDA’s decision last November to approve pembrolizumab as a first-line therapy for some(...)

The State of the Bladder Cancer Battle

The State of the Bladder Cancer Battle

Posted by  | Patient Stories

On a weekend before a business trip, Ken Brothers noticed some blood in his urine. He wondered if it was related his recent loss of 40 pounds on a medically-supervised diet and emailed his doctor about it. Blood in the urine is a common symptom of bladder cancer, but its presence is not always associated(...)

Is there any test for prostate cancer that doesn’t depend on a blood test for PSA?

Posted by  | Prevention/Screening

“There are an increasing collection of tests that sample other aspects of prostate cancer in urine, blood or tissue, including acquired gene defects in the disease and acquired changes that cancers display that normal cells don’t,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. “I would(...)

What are the signs of spiritual distress for cancer patients?

Posted by  | treatment

No matter how you respond to your diagnosis, it’s not unusual for cancer patients to feel the impact of spiritual pain and distress, says Rhonda Cooper, an oncology chaplain at the Johns Hopkins Kimmel Cancer Center in Baltimore.  Signs of spiritual distress for cancer patients may include: Guilt or regrets about things you have done(...)

How can I figure out if prostate cancer screening will help me personally?

Posted by  | Prevention/Screening

“The best approach is to have a significant conversation with your physician about the risks and benefits of screening. It's shared decision making,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. “People have different attitudes about what they’d like to do with their health. If someone(...)

Top Maryland scientists discuss research on tracking and treating cancer

Posted by  | Research

At the annual Research Matters conference yesterday, top scientists from the Johns Hopkins Kimmel Cancer Center and University of Maryland Greenebaum Cancer Center discussed research using advanced imaging methods to develop better ways pinpoint and track cancer cells — down to the microscopic level — and precisely target each cell with anti-cancer drugs. Experts also delivered presentations(...)

What you need to know about prostate cancer screening guidelines

Posted by  | Prevention/Screening

Prostate-specific antigen (PSA)-based screening for prostate cancer has received mixed reviews from different organizations, says William G. Nelson, M.D., Ph.D., director of the Johns Hopkins Kimmel Cancer Center. Today, the United States Preventive Services Task Force has posted draft recommendations for prostate screening that encourage men ages 55 - 69 to make individual decisions about(...)

Improving the ‘Care’ in Cancer Care

Posted by  | Uncategorized

*This blog post was written by the Kimmel Cancer Center's development specialist, Allison Rich. Anyone who has ever heard the words “you have cancer” knows that no part of their life remains unaffected by the reality of this diagnosis. Yet even though we know this to be true, the traditional approach to cancer medicine has(...)